US 9133200
Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors
granted A61KA61K31/437A61K31/5025
Quick answer
US patent 9133200 (Imidazo[1,2-b]pyridazine and imidazo[4,5-b]pyridine derivatives as JAK inhibitors) held by Almirall, S.A. expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Almirall, S.A.
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/437, A61K31/5025, A61K45/06, A61K9/2018